FDA inspection
Sciegen Pharmaceuticals Inc: FDA inspection ending Apr 21, 2023
FDA inspection 1204858 · Official Action Indicated (OAI) · Hauppauge, NY
Key facts
| Inspection ID | 1204858 |
|---|---|
| Firm | Sciegen Pharmaceuticals Inc |
| FEI number | 3008298016 |
| Address | 89 Arkay Dr |
| City | Hauppauge |
| State | NY |
| ZIP | 11788 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Apr 21, 2023 |
| Classification | Official Action Indicated (OAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data